NCT03197597View on ClinicalTrials.gov

EUpertstrain 4 Study of Bordetella Pertussis Isolates

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

October 12, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Bordetella Pertussis, Whooping Cough
Interventions
OTHER

Strain isolation from the nasopharynx

B. pertussis strains has been collected from the nasopharynx of the patients during the clinical visit

Trial Locations (1)

20014

University of Turku, Turku

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

University of Turku

OTHER

NCT03197597 - EUpertstrain 4 Study of Bordetella Pertussis Isolates | Biotech Hunter | Biotech Hunter